AngioDynamics ANGO Accounts payable and other current liabilities
Accounts payable and other current liabilities at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about AngioDynamics's accounts payable and other current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AngioDynamics's accounts payable and other current liabilities?
- AngioDynamics (ANGO) reported accounts payable and other current liabilities of -$6.01M in Q4 2025.
- How has AngioDynamics's accounts payable and other current liabilities changed year-over-year?
- AngioDynamics's accounts payable and other current liabilities increased by 45.2% year-over-year, from -$10.96M to -$6.01M.
- What is the long-term trend for AngioDynamics's accounts payable and other current liabilities?
- Over 2 years (2022 to 2024), AngioDynamics's accounts payable and other current liabilities has grown at a 165.3% compound annual growth rate (CAGR), from $3.91M to $27.53M.